BioFocus buys Cambridge Drug Discovery Holdings in a deal worth £27.5m

BioFocus buys Cambridge Drug Discovery Holdings in a deal worth £27.5m. BioFocus advised by Barlow Lyde & Gilbert (Peter Hill). Cambridge Drug Discovery Holdings advised by Weil Gotshal & Manges (James Gubbins).